Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Stenestrand

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Lakartidningen|November 22, 2005
["Time is a heart muscle". Quicker management and reperfusion save more patients with ST-segment elevation infarction]Ulf Stenestrand
Lakartidningen|October 13, 2009
[More patients with stable angina should be treated with PCI]Ulf Stenestrand
Lakartidningen|November 30, 2006
[Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents]Ulf Stenestrand
Lancet (London, England)|June 5, 2002
Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort studyUlf Stenestrand, Lars Wallentin
Archives of Internal Medicine|April 30, 2003
Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohortUlf Stenestrand, Lars Wallentin,
Lakartidningen|November 17, 2004
[The lower LDL cholesterol the better!]Ulf Stenestrand, Anders G Olsson
Heart (British Cardiac Society)|July 27, 2010
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIAJonas Oldgren, Lisa Wernroth, Ulf Stenestrand, et al.
European Heart Journal|January 24, 2007
Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgeryClaes Held, Per Tornvall, Ulf Stenestrand
American Heart Journal|January 22, 2005
Hospital therapy traditions influence long-term survival in patients with acute myocardial infarctionUlf Stenestrand, Johan Lindbäck, Lars Wallentin
Circulation|November 23, 2005
Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)Ulf Stenestrand, Johan Lindbäck, Lars Wallentin, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Lakartidningen|November 22, 2005
["Time is a heart muscle". Quicker management and reperfusion save more patients with ST-segment elevation infarction]Ulf Stenestrand
Lakartidningen|October 13, 2009
[More patients with stable angina should be treated with PCI]Ulf Stenestrand
Lakartidningen|November 30, 2006
[Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents]Ulf Stenestrand
Lancet (London, England)|June 5, 2002
Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort studyUlf Stenestrand, Lars Wallentin
Archives of Internal Medicine|April 30, 2003
Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohortUlf Stenestrand, Lars Wallentin,
Lakartidningen|November 17, 2004
[The lower LDL cholesterol the better!]Ulf Stenestrand, Anders G Olsson
Heart (British Cardiac Society)|July 27, 2010
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIAJonas Oldgren, Lisa Wernroth, Ulf Stenestrand, et al.
European Heart Journal|January 24, 2007
Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgeryClaes Held, Per Tornvall, Ulf Stenestrand
American Heart Journal|January 22, 2005
Hospital therapy traditions influence long-term survival in patients with acute myocardial infarctionUlf Stenestrand, Johan Lindbäck, Lars Wallentin
Circulation|November 23, 2005
Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)Ulf Stenestrand, Johan Lindbäck, Lars Wallentin, et al.
Pageof 5